Form 4: Intuitive Surgical CFO Exercises RSUs
Insider Transaction Report
Intuitive Surgical's EVP & CFO, Jamie Samath, acquired common stock through RSU vesting and simultaneously sold shares to cover tax obligations.
Summary
- Jamie Samath, Executive Vice President & Chief Financial Officer of Intuitive Surgical Inc. (ISRG), reported changes in beneficial ownership.
- On February 10, 2026, Samath acquired 1,077 shares of common stock through the vesting of Restricted Stock Units (RSUs) at an exercise price of $0.0.
- Concurrently, 496 shares were disposed of at a price of $492.84 per share to cover statutory tax withholding requirements related to the RSU vesting.
- Following these transactions, Samath directly beneficially owns 7,799 shares of Intuitive Surgical common stock.
- The RSUs vest 25% per year over a four-year period, commencing on each anniversary of February 10, 2023, subject to continuous service.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this filing as neutral to slightly positive. It reflects routine executive compensation and retention, with no unexpected or concerning elements. The RSU vesting is a pre-planned event.
Positives
- The vesting of 1,077 Restricted Stock Units (RSUs) indicates continued equity compensation for a key executive, aligning management's interests with shareholders.
- The acquisition of common stock at a $0.0 exercise price reflects the value of the RSU compensation plan.
Negatives
- A portion of the vested shares (496 shares) was sold to cover statutory tax withholding requirements, which is a routine event and not indicative of a negative outlook.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
StockSavvy.ai notes that this Form 4 filing represents a routine insider transaction related to executive compensation. The vesting of Restricted Stock Units and subsequent sale of shares to cover tax obligations is a common occurrence for executives receiving equity-based compensation in publicly traded companies within the medical device and technology sectors.
Stakeholder Impact
- Shareholders: The transaction is a routine part of executive compensation and does not indicate a significant shift in company strategy or financial health. It reinforces management's equity alignment.
- Employees: The RSU vesting demonstrates the company's commitment to equity-based compensation for its executives.
Next Steps
- Future vesting of the remaining Restricted Stock Units will occur annually on February 10, 2027, and February 10, 2028, subject to continuous service.
Key Dates
| Date | Description |
|---|---|
| 02/10/2023 | Commencement date for the four-year RSU vesting period (25% per year). |
| 02/10/2026 | Transaction date for RSU vesting and subsequent tax-related share disposition. |
Recommendation
holdThis Form 4 filing details a routine insider transaction involving the vesting of Restricted Stock Units and a subsequent sale of shares to cover tax liabilities. Such transactions are common for executives receiving equity compensation and typically do not provide new fundamental information that would warrant a change in investment recommendation. The filing confirms ongoing executive compensation alignment but offers no insights into operational performance or strategic shifts that would alter a seasoned investor's outlook on Intuitive Surgical's stock.
Keywords
Intuitive Surgical, ISRG, Form 4, Insider Transaction, Restricted Stock Units, RSU, Stock Vesting, CFO, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.